All In MedTech

PMA device

Enlite Sensor

Medtronic, Inc. · Automated Insulin Dosing , Threshold Suspend (OZO, Class III) · First FDA decision Nov 12, 2015, newest Nov 12, 2015Diabetes

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

PMA pathway

Device trials

30

Naming "Enlite"

MAUDE reports

25,717

Brand "Enlite", since 2015

PubMed studies

67

Mentioning "Enlite"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Enlite Sensor

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology, with pictures of the device
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Enlite", any status and sponsor, newest update first.

Open in Trial Radar
  • University of CambridgeAcademic, hospital or other

    NCT02871089 · 96 participants (planned) · Start Jan 2017 · Primary completion Jul 31, 2023

    Device: Closed-loop system (Florence M or CamAPS FX) · For: Diabetes Mellitus; Type 1 Diabetes

    Sites: Southampton, United Kingdom; Nottingham, United Kingdom; Oxford, United Kingdom · 7 sites in all

29 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Enlite", and for the whole product code for context.

This brand

25,717 reports: 22,333 malfunction, 3,345 injury, 32 death

Whole product code OZO

424,597 reports: 337,031 malfunction, 86,136 injury, 1,411 death

Newest reports for this brand

4 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Medtronic MiniMed, Inc.

    Z-1751-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026

    Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...

    Cause as FDA categorized it: Device Design · Device type: Automated Insulin Dosing , Threshold Suspend (OZO)

1 more recall records with a free account

Published research

The most relevant PubMed records for "Enlite"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code OZO.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.